ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) Study-Reference-Cited by-同舟云学术

ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) Study

Published:2010-01 Issue:1 Volume:11 Page:26-32
ISSN:1525-8610
Container-title:Journal of the American Medical Directors Association
language:en
Short-container-title:Journal of the American Medical Directors Association

Author:

Cesari Matteo,Pedone Claudio,Antonelli Incalzi Raffaele,Pahor Marco

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference42 articles.

1. Disability as a public health outcome in the aging population;Guralnik;Annu Rev Public Health,1996

2. Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study;Pahor;J Gerontol A Biol Sci Med Sci,2006

3. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance;Carter;J Gerontol A Biol Sci Med Sci,2005

4. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions;N Engl J Med,1992

5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39;BMJ,1998

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians;Molecular and Cellular Biochemistry;2024-05-29

2. Is sarcopenia an associated factor of increased administration of specific medications in patients with heart failure? A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-01-25

3. Fall-Risk-Increasing Drugs and Gait Performance in Community-Dwelling Older Adults: Exploratory Results from the Gait and Brain Study;Drugs & Aging;2023-06-22

4. Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin A;The Journals of Gerontology: Series A;2023-06-01

5. Interaction between sarcopenia and nonalcoholic fatty liver disease;Clinical and Molecular Hepatology;2023-02-28